See also this year's filing and all EDGAR filings for this company.
PDF Report 0001590750_2023_Viridian_Therapeutics_Inc_DE.pdf
Logs
Graph
Absolute values for 0001590750, Viridian Therapeutics Inc.\DE
| xvar | xval | |
|---|---|---|
| 0 | IntangibleAssets | 0 |
| 1 | AssetsNonCurrent | 2,592,000 |
| 2 | AssetsCurrent | 431,173,000 |
| 3 | PropertyPlantAndEquipment | 1,326,000 |
| 4 | remainder_Assets | 0 |
| 5 | LongTermLiabilities | 1,172,000 |
| 6 | LiabilitiesCurrent | 33,349,000 |
| 7 | remainder_Liabilities | 5,506,000 |
| 8 | LaborExpense | 0 |
| 9 | CostOfGoodsAndServicesSold | 0 |
| 10 | GeneralAndAdministrativeExpense | 35,182,000 |
| 11 | GoodwillImpairmentLoss | 0 |
| 12 | OperatingCostsAndExpenses | 0 |
| 13 | DepreciationDepletionAndAmortization | 0 |
| 14 | SellingAndMarketingExpense | 0 |
| 15 | ResearchAndDevelopmentExpense | 0 |
| 16 | remainder_Expenses | 100,894,000 |
| 17 | remainder_Revenues | 1,772,000 |
| 18 | remainder_NetIncome | 4,430,000 |
| 19 | remainder_ComprehensiveNetIncome | -233,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 435,091,000 |
| 1 | Liabilities | 40,027,000 |
| 2 | Expenses | 136,076,000 |
| 3 | Revenues | 1,772,000 |
| 4 | StockholdersEquity | 395,064,000 |
| 5 | NetIncome | -129,874,000 |
| 6 | ComprehensiveNetIncome | -130,107,000 |
| 7 | BaseVar | 332,328,815 |
| 8 | EconomicCapitalRatio | 2.08 |
Edgar->Model Mapping
Feature Distribution
Change over Time
